Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Infliximab is an appropriate second-line therapy in infants with steroid refractory pyoderma gangrenosum.
J Eur Acad Dermatol Venereol. 2022 May;36(5):e376-e378. doi: 10.1111/jdv.17921. Epub 2022 Jan 27.
J Eur Acad Dermatol Venereol. 2022.
PMID: 35037304
No abstract available.
Cite
Cite